Forte Biosciences, Inc.
FBRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $66,220 | $25,939 | $17,384 | $29,891 |
| - Cash | $22,244 | $11,961 | $41,100 | $42,044 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $43,976 | $13,978 | -$23,716 | -$12,153 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$39 | -$9 | $0 | -$36 |
| % Margin | – | – | – | – |
| EBITDA | -$35,439 | -$32,477 | -$13,860 | -$21,450 |
| % Margin | – | – | – | – |
| Net Income | -$35,478 | -$31,476 | -$13,862 | -$21,708 |
| % Margin | – | – | – | – |
| EPS Diluted | -12.17 | -24.92 | -19.96 | -38.854 |
| % Growth | 51.2% | -24.8% | 48.6% | – |
| Operating Cash Flow | -$30,745 | -$28,706 | -$8,185 | -$16,677 |
| Capital Expenditures | -$37 | -$88 | $0 | $0 |
| Free Cash Flow | -$30,782 | -$28,794 | -$8,185 | -$16,677 |